Fordyce Marshall

PRESIDENT AND CEO, DirectorVera Therapeutics, Inc. (VERA) · full profile →Form 4/A · filed Aug 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.0M
Net Open-Market Flow
-$2.0M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2026Option exercise(M)46K$2.90$134K281K
Jul 7, 2026Sell(S)1K$40.78$41K280K
Jul 7, 2026Sell(S)33K$42.07$1.4M248K
Jul 7, 2026Sell(S)11K$42.86$450K237K
Jul 7, 2026Sell(S)2K$43.59$96K235K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 7, 2026Option exercise(M)46K$0526K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001859453-26-000013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.